Global Trial Strategies for Patient Accessibility
Global Trial Strategies for Patient Accessibility Expanding Rare Disease Trial Access Through Global Patient-Centric Strategies Why Global Recruitment Is Essential for Rare Disease Trials Most rare diseases affect a small number of individuals—typically fewer than 200,000 in the U.S., and often less than 1 in 2,000 in the EU. When ultra-rare diseases are involved, patient…
Read More “Global Trial Strategies for Patient Accessibility” »